Feasibility and acceptability of patient- and clinician-level antithrombotic stewardship interventions to reduce gastrointestinal bleeding risk in patients using warfarin (Anticoagulation with Enhanced Gastrointestinal Safety): a factorial randomized controlled pilot trial-Reference-Cited by-同舟云学术

Feasibility and acceptability of patient- and clinician-level antithrombotic stewardship interventions to reduce gastrointestinal bleeding risk in patients using warfarin (Anticoagulation with Enhanced Gastrointestinal Safety): a factorial randomized controlled pilot trial

Published:2024-05 Issue:4 Volume:8 Page:102421
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Kurlander Jacob E.,Helminski Danielle,Yuan Liyang,Krein Sarah L.,Lanham Michael S.M.,Henstock Jennifer L.,Kidwell Kelley M.,De Vries Raymond,Resnicow Kenneth,Sholl Haden,Kim Joyce J.,Perry Linda K.,Parsons Jacqueline,Ha Nghi,Froehlich James B.,Aikens James E.,Richardson Caroline R.,Saini Sameer D.,Barnes Geoffrey D.

Funder

National Institutes of Health

Publisher

Elsevier BV

Reference34 articles.

1. US Emergency department visits attributed to medication harms, 2017-2019;Budnitz;JAMA,2021

2. Review article: gastrointestinal bleeding risk with direct oral anticoagulants;Benamouzig;Cardiovasc Drugs Ther,2022

3. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

4. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease

5. Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events;Schaefer;JAMA Intern Med,2019